Amgen Other Current Assets Over Time
| AMGN Stock | USD 311.41 2.96 0.96% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Amgen Performance and Amgen Correlation. Amgen |
Is Amgen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amgen. If investors know Amgen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amgen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.52) | Dividend Share 8.64 | Earnings Share 7.01 | Revenue Per Share 55.148 | Quarterly Revenue Growth 0.22 |
The market value of Amgen Inc is measured differently than its book value, which is the value of Amgen that is recorded on the company's balance sheet. Investors also form their own opinion of Amgen's value that differs from its market value or its book value, called intrinsic value, which is Amgen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amgen's market value can be influenced by many factors that don't directly affect Amgen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amgen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Amgen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amgen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Current Assets Analysis
Compare Amgen Inc and related stocks such as Merck Company, AbbVie Inc, and Gilead Sciences Other Current Assets Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MRK | 58.8 M | 3.7 B | 4.5 B | 4.8 B | 5.3 B | 5.2 B | 4.4 B | 4.3 B | 4.5 B | 4.3 B | 5.5 B | 7 B | 7.2 B | 7.6 B | 8 B |
| ABBV | 4 B | 2 B | 2 B | 2 B | 2.3 B | 1.5 B | 3.6 B | 4.7 B | 1.9 B | 2.4 B | 3.6 B | 5 B | 4.4 B | 4.9 B | 3.5 B |
| GILD | 100 K | 10 B | 797.7 M | 91.9 M | 472 M | 506 M | 1.1 B | 1.7 B | 1.6 B | 1.4 B | 2 B | 2.1 B | 1.8 B | 2.4 B | 1.3 B |
| JNJ | 246.4 M | 5.2 B | 6.2 B | 7.6 B | 7.1 B | 3 B | 3.3 B | 2.5 B | 3.6 B | 2.5 B | 3.1 B | 3.7 B | 3.1 B | 4.5 B | 3.4 B |
| BMY | 377 M | 1.5 B | 3.1 B | 10.5 B | 4.1 B | 2.5 B | 2.7 B | 576 M | 1.1 B | 2 B | 1.4 B | 1.3 B | 1.6 B | 1.5 B | 1.8 B |
| PFE | 130.9 M | 101 M | 70 M | 3.6 B | 2.8 B | 2.2 B | 2.2 B | 2.3 B | 2.5 B | 2.6 B | 3.4 B | 3.8 B | 5 B | 9.3 B | 9.7 B |
| LLY | 153.4 M | 813.4 M | 822.3 M | 755.8 M | 811.5 M | 604.4 M | 734.6 M | 1.4 B | 2.1 B | 2.5 B | 2.9 B | 2.5 B | 3 B | 149.5 M | 142 M |
| BIIB | 1.3 M | 2.1 B | 404.4 M | 478.8 M | 730.8 M | 1.2 B | 1.4 B | 1.5 B | 1.2 B | 1.2 B | 1.3 B | 1.2 B | 1.4 B | 1.2 B | 1.2 B |
Amgen Inc and related stocks such as Merck Company, AbbVie Inc, and Gilead Sciences Other Current Assets description
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.My Equities
My Current Equities and Potential Positions
Check out Amgen Performance and Amgen Correlation. Note that the Amgen Inc information on this page should be used as a complementary analysis to other Amgen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Amgen Stock analysis
When running Amgen's price analysis, check to measure Amgen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amgen is operating at the current time. Most of Amgen's value examination focuses on studying past and present price action to predict the probability of Amgen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amgen's price. Additionally, you may evaluate how the addition of Amgen to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Amgen technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.